Adverse drug events in pediatric patients

NIAID Data Ecosystem2026-05-02 收录

用药安全

药物不良事件

数据链接：

https://data.mendeley.com/datasets/zd3dz6bhsg 数据链接链接失效反馈

官方服务：

资源简介：

This dataset results from a data collection process and data analysis of a reasearch on adverse drug events in children.

创建时间：

2025-03-17

Adverse events in patients taking macrolide antibiotics versus placebo for any indication: Supplementary data set B

用药安全

不良事件分析

Supplementary data B Any reported adverse event that occurred in less than 5% of any group – grouped under the primary System Organ Class, according to the MedDRA coding system.

Research Data Australia80

Number of subjects presenting possible or probable related adverse events.

药物不良事件

临床试验安全性评估

Number of subjects presenting possible or probable related adverse events.

NIAID Data Ecosystem40

IMB-1901药理、药效学数据

抗菌药

用药安全

该数据集包括1个word文档，描述了IMB-1901体内外抗菌活性和急性毒性数据，实验中所用菌株为本实验室（中国医学科学院病原微生物菌毒种保藏中心药用微生物菌毒种保藏分中心）保存的ATCC菌株和临床分离菌株，采集方法为琼脂稀释法、小鼠全身感染死亡率测定等。

国家人口健康科学数据中心30

Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy Chinese volunteers: A randomized, double-blind, placebo-controlled, ascending-dose study

用药安全

临床试验

Ulinastatin, is a broad-spectrum protease inhibitor purified from human urine, inhibits endogenous proteases such as trypsin, α-chymotrypsin, hyaluronidase, and plasmin. It is widely being used at inc

NIAID Data Ecosystem60

Comparing musculoskeletal and connective tissue disorder risks of Teriparatide and abaloparatide in osteoporosis: an analysis based on FDA adverse event reporting system (FAERS)

用药安全

骨质疏松症

Osteoporosis (OP) is a common skeletal disorder characterized by decreased bone mass and increased fracture risk. Anabolic agents such as teriparatide (TP) and abaloparatide (ABL) have been introduced

Taylor & Francis Group2025-08-07 更新30

Adverse drug events in pediatric patients

资源简介：

相关数据集